Author Correction: Enhancing untargeted metabolomics using metadata-based source annotation.
Author Correction: Enhancing untargeted metabolomics using metadata-based source annotation.
复制标题
作者更正：使用基于元数据的源注释增强非目标代谢组学。
DOI：
10.1038/s41587-023-02025-x
复制
发表时间：
2023
影响因子：
46.9
通讯作者：
Meehan
中科院分区：
文献类型：
--
作者：
Gauglitz,JuliaM;West,KianaA;Bittremieux,Wout;Williams,CandaceL;Weldon,KellyC;Panitchpakdi,Morgan;DiOttavio,Francesca;Aceves,ChristineM;Brown,Elizabeth;Sikora,NicoleC;Jarmusch,AlanK;Martino,Cameron;Tripathi,Anupriya;Meehan
在最初发表的文章版本中，“利益竞争声明”的一部分缺失：“DM是BiomeSense， Inc.的顾问，拥有股权并获得收入。这些安排的条款已经由加州大学圣地亚哥分校根据其利益冲突政策进行了审查和批准。RK是BiomeSense， Inc.的科学顾问委员会成员和顾问，拥有股权和收入。他是科学顾问委员会成员，并拥有GenCirq的股权。他是DayTwo的顾问和科学顾问委员会成员，并获得收入。他拥有赛贝勒的股权，并担任该公司的顾问。他是Biota， Inc.的联合创始人，并拥有股权。他是microroma的联合创始人，并拥有股权和科学顾问委员会成员。这一安排的条款已经由加州大学圣地亚哥分校根据其利益冲突政策进行了审查和批准。”文本已插入到文章的HTML和PDF版本中。
In the version of the article initially published, a portion of the Competing interests statement was missing:“DM is a consultant for BiomeSense, Inc., has equity and receives income. The terms of these arrangements have been reviewed and approved by the University of California, San Diego in accordance with its conflict of interest policies. RK is a scientific advisory board member, and consultant for BiomeSense, Inc., has equity and receives income. He is a scientific advisory board member and has equity in GenCirq. He is a consultant and scientific advisory board member for DayTwo, and receives income. He has equity in and acts as a consultant for Cybele. He is a co-founder of Biota, Inc., and has equity. He is a cofounder of Micronoma, and has equity and is a scientific advisory board member. The terms of this arrangement have been reviewed and approved by the University of California, San Diego in accordance with its conflict of interest policies.” The text has been inserted in the HTML and PDF versions of the article.